Overview

Home Based Infusions for Ocrelizumab

Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The goal is to assess the safety and effectiveness of home ocrelizumab infusion.
Phase:
Phase 4
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
Genentech, Inc.
Treatments:
Ocrelizumab